| 產(chǎn)品編號 |
Y-0113 |
| 英文名稱 |
beta Amyloid 1-40 (mutation type, MT) Peptide
|
| 中文名稱 |
突變型β淀粉樣肽1-40多肽 |
| 別 名 |
beta Amyloid(1-40); beta Amyloid 1-40; beta-Amyloid 1-40; Amyloid 1-40; A Beta 1-40; A4; AAA; ABETA; ABPP; AD1; Alzheimers Disease Amyloid Protein; Amyloid B; Amyloid Beta A4 Protein Precursor; Amyloid Beta; Amyloid of Aging and Alzheimer Disease; APP; AP |
| 理論分子量 |
kDa |
| 檢測分子量 |
|
| 性 狀 |
Lyophilized |
| 序 列 |
DAEFRd-HDSGYEVd-Hd-HQKLVFFAEDVGSNKGAIIGLMVGGVV(d-H6;d-H13;d-H14) |
| 純化方法 |
HPLC |
| 活性 |
Yes |
| 保存條件 |
Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 |
The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid antibodies and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
|
|
|
